Publication Cover
Natural Product Research
Formerly Natural Product Letters
Volume 31, 2017 - Issue 5
457
Views
20
CrossRef citations to date
0
Altmetric
Research Article

Isolation of a new β-carboline alkaloid from aerial parts of Triclisia sacleuxii and its antibacterial and cytotoxicity effects

, , , &
Pages 529-536 | Received 29 Jun 2015, Accepted 02 Jun 2016, Published online: 03 Jul 2016
 

Abstract

A new β-carboline alkaloid named sacleuximine A (1) together with known compounds palmatine (2), isotetrandrine (3), trans-N-feruloyltyramine (4), trans-N-caffeoyltyramine (5), yangambin (6), syringaresinol (7), sesamin (8), (+) epi-quercitol (9), 4-hydroxybenzaldehyde (10), β-sitosterol (11), quercetin 3-O-rutinoside (12) and myricetin 3-O-β-glucose (1→6) α-rhamnoside (13) have been isolated from methanol extract of Triclisia sacleuxii aerial parts. Compounds 1–10 were evaluated for their cytotoxicity against human adenocarcinoma (HeLa), human hepatocarcinoma (Hep3B) and human breast carcinoma (MCF-7) cells lines and also for antibacterial activities against both Gram-positive and Gram-negative bacteria. The cytotoxicity (IC50) values ranged between 0.15 and 36.7 μM while the minimum inhibitory concentrations were found to be in the range of 3.9 and 125 μM, respectively. This is the first report of antibacterial compounds and the isolation of lignans together with a β-carboline alkaloid from T. sacleuxii.

Acknowledgments

This work was supported by the National Commission for Science, Technology and Innovation (NACOSTI) and Germany Academic Exchange Services (DAAD). The authors are grateful to Mr. Mutiso (Taxonomist) of Botany department, University of Nairobi for identification and collection of the plant materials and Mr. James Odhiambo of the School of Public Health, Maseno University for conducting the bioassay experiments. The Institute of Organic Chemistry, Johannes Gutenberg University at Mainz, Germany is acknowledged for the spectroscopic data.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.